Clinical, histologic, and
DUPIXENT was studied across
The safety of DUPIXENT was
evaluated through 24 weeks in the
multi-part, phase 3 clinical trial.
Support can make all the difference. DUPIXENT MyWay® is a patient support program that can help enable access to DUPIXENT and offers financial assistance for eligible patients, one-on-one nursing support, and more.